What did @greaterwestcovina actually say?
The video promotes a new hormone replacement therapy service at a West Covina med spa, offering injections, creams, and pellets. The creator says HRT is for anyone with symptoms like fatigue, hot flashes, low libido, or hair loss, starting in the late 30s and early 40s for both men and women. Most notably, they describe a system that "calculates the perfect dosage" from bloodwork, then sets patients on a schedule of two to four visits per year depending on sex. The phrase "perfect dosage" is doing a lot of heavy lifting here, and it deserves scrutiny.
The conversation is casual, co-presenter format, and the tone is enthusiastic rather than clinical. There is no mention of a physician overseeing the protocol, no discussion of contraindications, and no acknowledgment that HRT carries documented risks. That is not a minor omission.
Does the science back this up?
Partially. The symptom list is real, but the framing oversimplifies how hormone optimization actually works in clinical practice. The Endocrine Society's 2018 clinical practice guidelines on testosterone therapy are clear: diagnosis of hypogonadism requires two fasting morning testosterone measurements on separate days, not one round of bloodwork fed into a software system. The idea that an algorithm outputs a "perfect dosage" contradicts how hormone metabolism actually behaves across individuals.
For women, the picture is even more complicated. The 2022 Menopause Society position statement notes that HRT decisions must account for cardiovascular history, breast cancer risk, clotting disorders, and more. Symptom-based eligibility alone, which is essentially what this video describes, is not a safe or sufficient screening protocol. Hair loss, fatigue, and low libido are also nonspecific symptoms with many possible causes. Jumping to hormone therapy without ruling out thyroid dysfunction, anemia, or sleep apnea, for example, is a clinical shortcut that can cause real harm.
What did they get wrong (or right)?
Credit where it is due: requiring bloodwork before starting HRT is the right call, and following up with repeat labs to adjust dosing is standard practice. Endocrine Society guidelines and the American Urological Association both recommend this. They got that part right.
Where it falls apart is the "perfect dosage" claim. No algorithm calculates a perfect hormone dose from a single blood draw. Hormone levels fluctuate based on time of day, recent sleep, stress, and lab methodology. Morgentaler et al. (2016, Mayo Clinic Proceedings) documented that testosterone results vary significantly even within the same individual across short time windows. Calling any output "perfect" is marketing language, not medicine.
The twice-per-year follow-up schedule for men also raises questions. The AUA recommends more frequent monitoring during the first year of testosterone therapy, specifically at three and six months, before extending to annual or semi-annual visits. Jumping straight to twice-yearly oversight for a new patient is below standard-of-care frequency.
What should you actually know?
HRT is a legitimate and often effective treatment for documented hormone deficiency. It is not a lifestyle upgrade for anyone who feels "frumpy." That word choice matters because it implies the treatment is appropriate for a broad, vaguely defined population, which is exactly how over-prescribing starts.
Before starting any hormone therapy, you should expect: at minimum two separate hormone panels, a full metabolic panel, screening for contraindications specific to your sex and health history, and a licensed physician, not just a nurse practitioner or a med spa algorithm, reviewing your case. Pellet therapy in particular has a higher rate of supraphysiologic dosing than injections or creams, which carries its own risks including polycythemia and cardiovascular strain (Shoskes et al., 2016, Urology).
If a provider's primary pitch is that their system computes the "perfect" dose and then you come back twice a year, ask harder questions. Good hormone management is iterative, not algorithmic.